Cargando…
An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell p...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198963/ https://www.ncbi.nlm.nih.gov/pubmed/9207003 |
_version_ | 1782148102129451008 |
---|---|
author | McKinnon, Murray Page, Kevin Uings, Iain J. Banks, Martyn Fattah, Dilniya Proudfoot, Amanda E.I. Graber, Pierre Arod, Christian Fish, Richard Wells, Timothy N.C. Solari, Roberto |
author_facet | McKinnon, Murray Page, Kevin Uings, Iain J. Banks, Martyn Fattah, Dilniya Proudfoot, Amanda E.I. Graber, Pierre Arod, Christian Fish, Richard Wells, Timothy N.C. Solari, Roberto |
author_sort | McKinnon, Murray |
collection | PubMed |
description | Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5–dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5–dependent functional responses and reveals distinct mechanisms of receptor/cellular activation. |
format | Text |
id | pubmed-2198963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21989632008-04-16 An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils McKinnon, Murray Page, Kevin Uings, Iain J. Banks, Martyn Fattah, Dilniya Proudfoot, Amanda E.I. Graber, Pierre Arod, Christian Fish, Richard Wells, Timothy N.C. Solari, Roberto J Exp Med Article Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5–dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5–dependent functional responses and reveals distinct mechanisms of receptor/cellular activation. The Rockefeller University Press 1997-07-07 /pmc/articles/PMC2198963/ /pubmed/9207003 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article McKinnon, Murray Page, Kevin Uings, Iain J. Banks, Martyn Fattah, Dilniya Proudfoot, Amanda E.I. Graber, Pierre Arod, Christian Fish, Richard Wells, Timothy N.C. Solari, Roberto An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title | An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title_full | An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title_fullStr | An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title_full_unstemmed | An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title_short | An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils |
title_sort | interleukin 5 mutant distinguishes between two functional responses in human eosinophils |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198963/ https://www.ncbi.nlm.nih.gov/pubmed/9207003 |
work_keys_str_mv | AT mckinnonmurray aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT pagekevin aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT uingsiainj aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT banksmartyn aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT fattahdilniya aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT proudfootamandaei aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT graberpierre aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT arodchristian aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT fishrichard aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT wellstimothync aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT solariroberto aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT mckinnonmurray interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT pagekevin interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT uingsiainj interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT banksmartyn interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT fattahdilniya interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT proudfootamandaei interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT graberpierre interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT arodchristian interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT fishrichard interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT wellstimothync interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils AT solariroberto interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils |